Staff sergeant defrauds regiment to buy cars and hair transplant
An Army staff sergeant who defrauded his regiment out of more than £330,000 to buy luxury cars, a hair transplant and 'adult services' has been jailed.
Andrew Oakes, 39, used his position as financial systems administrator at the Catterick Garrison base in North Yorkshire to transfer £336,448 of public funds into his personal accounts.
He used the funds to buy three Tesla cars, a Mini Cooper and a Nissan Qashqai, along with Apple products, a hair transplant and spent £16,500 on 'adult services'.
He also paid off debts by writing cheques to himself and disguising the transactions by falsifying stubs in the names of legitimate suppliers, including a regimental accountant and tailoring company.
Oakes appeared for sentence on Thursday at Teesside Crown Court after pleading guilty to three counts of fraud by false representation, fraud by abuse of a position of trust and acquiring criminal property between February 2021 and October 2024.
He was jailed for three-and-a-half years.
Prosecutor Tabitha Buck said the role as a financial systems administrator was given to 'trustworthy' personnel because it gave them restricted but 'significant' access to MoD funds.
In August 2024, Oakes was quizzed by his military line manager after she uncovered 'multiple suspicious transactions in the system' and reported this to the Royal Military Police.
It emerged the scam first got under way in February 2021 when Oakes falsified his bank statements to try to prove that he had £300,000 available to secure a mortgage for a property, claiming he had won the money in 'the army lottery'.
Between July 2021 and April 2022, he created false local authority and utility documents to claim £1,584 of mileage allowance.
It was in May 2024 that the deception originally came to light, by which time Oakes had written 28 government cheques to himself.
The investigation was then passed on to MoD's Economic Crime Team.
He was fraudulently taking 'extensive periods of leave' on compassionate and medical grounds claiming that a family member had died.
Oakes took 66 medical-leave days and 12 on 'compassionate' grounds, which first 'raised a red flag' among his military bosses.
His military line manager said she had been supportive and sympathetic towards Oakes due to the 'family bereavement' and his perceived personal circumstances, which gave rise to his request for leave on compassionate grounds.
Oakes, who was representing himself in court, said: 'I just want to apologise to everyone I've hurt – family and the Army especially. I was in a very bad place, drinking a lot of alcohol.'
He said he wasn't a 'stable' individual at the time, adding: 'I regret everything I've done.'
Judge Nathan Adams said that Oakes had 'wholly abused' a position of trust, prestige and 'high responsibility' in which he was given 'significant' access to state defence funds.
He added: 'The impact of your offending is not simply the financial loss to the public purse but also the reputational damage caused to the organisation as a while, to Catterick and your battalion.
'Those officers who supported you with your personal problems felt significantly betrayed when they found out what was really going on and it's had a significant impact on the morale of your battalion in Catterick.'
Mr Adams acknowledged Oakes did have genuine personal issues at the time, including the breakdown of his relationship with his former partner, which led to a drink problem.
Oakes, of Station Road, Winsford, Cheshire, received a three-and-a-half-year jail sentence but was told under the Government's early-release scheme he would serve less than half of that time behind bars before being released on licence.
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
29 minutes ago
- CBS News
FBI seek man wanted in Kildeer, Illinois bank robbery
Authorities are searching for a man they said robbed a bank Friday morning in far northwest suburban Kildeer. The FBI says he robbed a Bank of America on Rand Road around 10:30 a.m. Investigators said he gave a note to the teller implying he had a gun, but he didn't pull one out. He got away with an unspecified amount of cash and drove off in a newer model GMC Acadia. No Injuries were reported. The suspect was described as a white man about 5-feet-7-inches tall, 210 pounds, and around 60 years old. He was last seen wearing a dark jacket, gray shirt, and black and silver glasses. FBI Kildeer police and the FBI are asking anyone with information, specifically anyone who was driving a Tesla vehicle in the vicinity of the bank and the Whole Foods parking lot between 10 and 10:30 a.m., to contact the FBI Chicago North Office at 847-734-9833 or the Kildeer Police Department at 847-438-6644.
Yahoo
40 minutes ago
- Yahoo
Tesla EV registrations in the US fall 16% in April
Tesla (TSLA) electric vehicle registrations in the United States fell by 16% in April, acording to the latest data out from S&P Global Mobility. Yahoo Finance senior autos reporter Pras Subramanian dives into the report and weighs in on CEO Elon Musk's criticisms of President Trump's "big, beautiful" tax and spending bill and the delay of Tesla's robotaxi launch in Austin, Texas. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. Tesla US registrations sliding 16% in April. That's according to data from S&P Global mobility. Joining us now from the Nasdaq Yahoo! Finance senior autos reporter Pras Subramanian. So Pras, um, what is what is this data telling us about sort of, I guess things that Tesla don't seem to be getting much better. Yeah, it's the first indication now we're seeing now US data, right? So registration data from S&P Global mobility showed that 16% drop in April year over year. Uh, this is happening while other competitors like Chevy and BMW see sales gains. So with regards to Tesla, uh, every model except the Model 3 saw sales drop in the US in April. And this is sort of coming on the backdrop of what we saw in Europe, right? We saw a lot of bad data there for sales data in Europe, mostly recently for for April and May there. So we're seeing an echo here in the US, but I want to quickly touch on the fact that, you know, we mentioned Chevy at number two, the very popular Equinox and Blazer EV doing well. BMW also there having some good models. They're seeing some sales gains. And then and Tesla overnight last night, maybe looking to address that the top in the market, updated the Model S and Model X vehicles there. So new updates there potentially to stem the losses and on the top end, but but nonetheless is still a pattern that we're seeing that has been recurring throughout the Western world and also now in the US now with April data. And Pros of course, if people investors in Tesla have been watching other things, namely, what seems to be sort of, you know, warming, if not warming relations, at least not further cooling relations between the president and Elon Musk, and also they're looking ahead to the robo taxi launch, which has been pushed back, yes to June 22nd. So we'll see if it if it gets pushed back more, but there does seem to be some optimism building around some of this stuff. Yeah, you saw Musk backtrack a little bit on those comments he made last week about the the the big beautiful bill talking about how it didn't really cut a lot of the spending, but mostly with the subtext of him being upset about potential loss to EV tax credit. That being said, the robo taxi launch are testing in Austin is happening. Uh we've seen some cars going back and forth to chase vehicles, but the actual official start Musk says won't happen till the 22nd. That was a push back from the 12th that was previously reported. And Musk also said the 22nd date could be pushed back just just because of of safety and precaution looking to be sort of cover all their bases with such a big high profile test happening in that city. But you know, we talked about this before, this is a big news for Tesla, big move. They need to do that to unlock the value, but you know, Waymo's been operating in Austin and also other cities for for some time now. So they have a lot of catching up to do when it comes to that robo taxi business. Yes. We'll see how it plays out. Pras, thank you. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Forbes
44 minutes ago
- Forbes
5 Stocks To Buy As The Stock Market Nears All-Time Highs
The stock market's remarkable recovery from earlier 2025 volatility has investors questioning whether it's still a good time to buy. The S&P 500 hit 6,000 for the first time since February following strong economic data. Subsequently, it fell to a low of 4,910 in April due to Tariff concerns and investor pessimism as Trump rolled out his new economic plans. In May, it bounced back, and despite ongoing Tariff concerns, the S&P 500 closed out the Month with a gain of more than 6%, its best monthly performance since November 2023. Current market conditions present both opportunities and challenges for investors. While some analysts worry about overvaluation, earnings estimates have been revised to 7% growth for 2025, suggesting markets are no longer priced for an adverse outcome. The recent recovery from the spring market correction demonstrates the resilience of quality companies with strong fundamentals. The methodology for selecting these five stocks focused on companies with compelling growth prospects, strong competitive positions and the ability to thrive in various market conditions. I analyzed quantitative metrics, including revenue growth, profit margins and valuation ratios, while also considering qualitative factors such as market leadership, innovation capabilities and long-term strategic positioning. These selections represent diverse sectors that are well-positioned to benefit from current economic trends. Tesla remains the world's leading electric vehicle manufacturer, with expanding operations in energy storage, solar panels and autonomous driving technology. The company has successfully scaled production across multiple global facilities while maintaining industry-leading margins. Despite recent volatility stemming from tensions around Elon Musk's involvement in the U.S. Department of Government Efficiency (DOGE), which temporarily cut $152 billion from Tesla's market capitalization, the underlying business fundamentals remain strong, with growing EV adoption worldwide. Tesla's market leadership in the rapidly expanding electric vehicle (EV) sector positions it perfectly for long-term growth. The company's vertical integration strategy, from battery production to charging infrastructure, creates substantial competitive advantages. Recent developments in autonomous driving technology and energy storage solutions provide multiple revenue streams beyond traditional automotive sales. The temporary price decline from Elon Musk's entanglement with politics and perhaps declining mental stability creates an attractive entry point for long-term investors. Tesla's global expansion, particularly in emerging markets, combined with decreasing battery costs and improving production efficiency, suggests strong earnings growth potential. The company's innovation pipeline, which includes robotaxi services and energy grid solutions, offers significant upside beyond its current valuations. Microsoft stands as one of the world's most valuable companies, dominating cloud computing through Azure, productivity software via Office 365 and emerging AI technologies. The company has successfully transitioned from traditional software licensing to subscription-based services, creating predictable recurring revenue streams. Microsoft shares advanced significantly in early May, with AI developments reigniting investor interest. Microsoft's diversified business model provides stability and growth across multiple technology sectors. The company's leadership in cloud computing continues to expand as enterprises accelerate their digital transformation initiatives. Azure's growth trajectory, combined with Microsoft's early integration of AI across its product suite, positions the company perfectly for the next wave of technology. Microsoft recently secured a significant deal to bring 1 million Copilot users on board from a single enterprise client, potentially generating over $350 million annually. This adds momentum to its AI strategy, following strong Q3 earnings and record-high share prices. With Azure growth holding steady and demand for AI-integrated tools on the rise, the deal reinforces Microsoft's position as a market leader. At the same time, the stock trades at a premium, continued execution in cloud and AI could justify the valuation, and support further upside. Palantir specializes in big data analytics and artificial intelligence platforms, serving government agencies and commercial enterprises. The stock has surged nearly 75% this year, leading the Nasdaq 100's constituents so far in 2025, driven by expanding federal government contracts and growing commercial adoption. The company's unique position in data integration and analysis creates substantial competitive moats. Palantir's government contracts provide stable, long-term revenue streams with high switching costs due to the mission-critical nature of their platforms. The company's work for the federal government has grown substantially, creating predictable cash flows that support aggressive growth investments. The expanding commercial segment demonstrates Palantir's ability to monetize its technology beyond government applications. The company's AI and machine learning capabilities position it perfectly for the current technology cycle. As organizations increasingly rely on data-driven decision making, Palantir's platforms become essential infrastructure. The high barriers to entry in this specialized market, combined with strong customer retention rates, suggest sustainable competitive advantages that justify premium valuations. Johnson & Johnson represents one of the world's largest healthcare conglomerates, with diversified operations spanning pharmaceuticals, medical devices and consumer products. The company sustains a broad economic moat through outstanding cash flow generation, a growing research pipeline, and multiple revenue sources. Recent strategic acquisitions, including the $14.6 billion purchase of Intra-Cellular, a biopharmaceutical business, demonstrate ongoing portfolio optimization. Johnson & Johnson's defensive characteristics make it an ideal holding during market volatility, while its pharmaceutical pipeline provides significant growth potential. The company's consistent dividend payments, supported by strong cash flows, offer income stability that's particularly attractive in uncertain economic environments. J&J's global reach and diversified product portfolio provide resilience against regional economic downturns. The healthcare sector's demographic tailwinds, driven by aging populations worldwide, create sustained demand for Johnson & Johnson's products and services. The company's strong research and development capabilities, combined with strategic acquisitions, continuously refresh its product pipeline. J&J's excellent credit rating and financial flexibility enable continued investment in growth opportunities while maintaining shareholder returns. HIMS & Hers operates a direct-to-consumer telemedicine platform, offering personalized healthcare solutions that include treatments for hair loss, sexual wellness, mental health and skincare. The company reported a significant increase in net income for the fourth quarter, generating $26 million in net income, up from $5 million in the same period last year. The platform's subscription-based model creates recurring revenue streams with high customer lifetime value. The digital healthcare revolution accelerated by the pandemic has created permanent behavioral changes in how consumers access healthcare services. HIMS capitalizes on this trend by offering convenient and affordable alternatives to traditional healthcare delivery. The company's direct-to-consumer model eliminates intermediaries, improving margins while reducing costs for patients. HIMS addresses large, underserved markets where traditional healthcare often fails to provide adequate solutions. The company's focus on stigmatized conditions creates intense customer loyalty and reduces price sensitivity. Expanding product offerings and geographic reach provide multiple growth vectors, while the subscription model ensures predictable revenue growth. The digital-first approach positions HIMS perfectly for the future of personalized healthcare delivery. Bottom Line These five stocks represent compelling opportunities as markets near all-time highs, each offering unique advantages for different investor profiles. Tesla provides exposure to the electric vehicle (EV) revolution, Microsoft offers stability with AI growth, Palantir captures the data analytics boom, Johnson & Johnson delivers defensive income with growth potential, and HIMS capitalizes on the digital healthcare transformation. While market timing remains uncertain, these quality companies with strong competitive positions and compelling growth prospects offer attractive risk-adjusted returns for long-term investors navigating today's elevated market levels.